Development of an adherence-enhancing intervention in topical treatment termed the topical treatment optimization program (TTOP)

Archives of Dermatological Research

Volumn 306, Issue 7, 2014, Pages 667-676

  Reich, Kristian ^a   Mrowietz, Ulrich ^b   Karakasili, Eleni ^c   Zschocke, Ina ^c  

^a DERMATOLOGIKUM HAMBURG   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c SCIderm GmbH   (Germany)

Author keywords

Adherence; Intervention; Psoriasis; Topical therapy; TTOP

Indexed keywords

ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DISEASE ACTIVITY; DOCTOR PATIENT RELATION; HEALTH CARE PERSONNEL; HUMAN; INTERVIEW; MEDICATION COMPLIANCE; MEDLINE; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PSORIASIS; QUALITY OF LIFE; QUESTIONNAIRE; SYSTEMIC THERAPY; TOPICAL TREATMENT; TREATMENT OUTCOME; FEMALE; INFORMATION PROCESSING; INTRADERMAL DRUG ADMINISTRATION; MALE; PATIENT EDUCATION; PROCEDURES; PSYCHOLOGY;

ADMINISTRATION, CUTANEOUS; DATA COLLECTION; FEMALE; FOCUS GROUPS; HUMANS; MALE; MEDICATION ADHERENCE; PATIENT EDUCATION AS TOPIC; PSORIASIS; TREATMENT OUTCOME;

EID: 84906790666     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-014-1475-5     Document Type: Article

References (82)

1. Anderson B (2007) Collaborative care and motivational interviewing: improving depression outcomes through patient empowerment interventions. Am J Manag Care 13:S103-S106
2. Augustin M, Chapnik K, Gupta S, Buesch K, Radke M (2011) Psoriasis causes high costs, reduces productivity at work and quality of life. Aktuelle Dermatol 37:353-359
3. Augustin M, Holland B, Dartsch D, Langenbruch A, Radtke MA (2011) Adherence in the treatment of psoriasis: a systematic review. Dermatology 222:363-374
4. Balkrishnan R, Carroll CL, Camacho FT, Feldman SR (2003) Electronic monitoring of medication adherence in skin disease: results of a pilot study. J Am Acad Dermatol 49:651-654 (Pubitemid 37210278)
5. Barber N, Parsons J, Clifford S, Darracott R, Horne R (2004) Patients' problems with new medication for chronic conditions. Qual Saf Health Care 13:172-175 (Pubitemid 38797501)
6. Bewley A, Page B (2011) Maximizing patient adherence for optimal outcomes in psoriasis. J Eur Acad Dermatol Venereol 25:9-14
7. Brawley LR, Culos-Reed SN (2000) Studying adherence to therapeutic regimens: overview, theories, recommendations. Control Clin Trials 21:156S-163S
8. Brown KK, Wingfield ER, Kimball AB (2006) Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis. J Am Acad Dermatol 55:607-613 (Pubitemid 44436629)
9. Brown MT, Bussell JK (2011) Medication adherence: WHO cares? Mayo Clin Proc 86(4):304-314
10. Carroll CL, Feldman SR, Camacho FT, Balkrishnan R (2004) Better medication adherence results in greater improvement in severity of psoriasis. Br J Dermatol 151:895-897 (Pubitemid 39482127)
11. Carroll CL, Feldman SR, Camacho FT, Manuel JC, Balkrishnan R (2004) Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol 51:212-216
12. Culos-Reed SN, Rejeski WJ, McAuley E, Ockene JK, Roter DL (2000) Predictors of adherence to behavior change interventions in the elderly. Control Clin Trials 21:200S-205S
13. de Korte J, Van Onselen J, Kownacki S, Sprangers MA, Bos JD (2005) Quality of care in patients with psoriasis: an initial clinical study of an international disease management programme. J Eur Acad Dermatol Venereol 19:35-41 (Pubitemid 40268138)
14. Dimatteo MR, Giordani PJ, Lepper HS, Croghan TW (2002) Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 40:794-811
15. Elliott R (2009) Non-adherence to medicines: not solved but solvable. J Health Serv Res Policy 14:58-61
16. Ellis S, Shumaker S, Sieber W, Rand C (2000) Adherence to pharmacological interventions. Current trends and future directions. The Pharmacological Intervention Working Group. Control Clin Trials 21:218S-225S
17. Evers AW, Kleinpenning MM, Smits T, Boezeman J, van de Kerkhof PC, Kraaimaat FW, Gerritsen MJ (2010) Treatment nonadherence and long-term effects of narrowband UV-B therapy in patients with psoriasis. Arch Dermatol 146:198-199
18. Falvo D, Tippy P (1988) Communicating information to patients. Patient satisfaction and adherence as associated with resident skill. J Fam Pract 26:643-647
19. Farrer L, Christensen H, Griffiths KM, Mackinnon A (2011) Internet-based CBT for depression with and without telephone tracking in a national helpline: randomised controlled trial. PLoS One 6:e28099
20. Feldman S, Behnam SM, Behnam SE, Koo JY (2005) Involving the patient: impact of inflammatory skin disease and patient-focused care. J Am Acad Dermatol 53:S78-S85 (Pubitemid 40828184)
21. Feldman SR (2010) Approaching psoriasis differently: patient-physician relationships, patient education and choosing the right topical vehicle. J Drugs Dermatol 9:908-911
22. Feldman SR, Camacho FT, Krejci-Manwaring J, Carroll CL, Balkrishnan R (2007) Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol 57:81-83 (Pubitemid 46908856)
23. Feldman SR, Horn EJ, Balkrishnan R, Basra MK, Finlay AY, McCoy D, Menter A, van de Kerkhof PC, International Psoriasis Council (2008) Psoriasis: improving adherence to topical therapy. J Am Acad Dermatol 59:1009-1016
24. Finlay AY, Coles EC (1995) The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 132:236-244
25. Fouere S, Adjadj L, Pawin H (2005) How patients experience psoriasis: results from a European survey. J Eur Acad Dermatol Venereol 19(Suppl 3):2-6 (Pubitemid 41726918)
26. Fuertes JN, Mislowack A, Bennett J, Paul L, Gilbert TC, Fontan G, Boylan LS (2007) The physician-patient working alliance. Patient Educ Couns 66:29-36 (Pubitemid 46366607)
27. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB (2006) Risk of myocardial infarction in patients with psoriasis. J Am Med Assoc 296:1735-1741 (Pubitemid 44547793)
28. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X (2008) Interventions for enhancing medication adherence. Cochrane Database Syst Rev (2):CD000011. doi: 10.1002/14651858.CD000011.pub3
29. Hays RD, Kravitz RL, Mazel RM, Sherbourne CD, Dimatteo MR, Rogers WH, Greenfield S (1994) The impact of patient adherence on health outcomes for patients with chronic disease in the Medical Outcomes Study. J Behav Med 17:347-360 (Pubitemid 24255227)
30. Hodari KT, Nanton JR, Carroll CL, Feldman SR, Balkrishnan R (2006) Adherence in dermatology: a review of the last 20 years. J Dermatol Treat 17:136-142
31. Hong J, Koo B, Koo J (2008) The psychosocial and occupational impact of chronic skin disease. Dermatol Ther 21:54-59 (Pubitemid 351342175)
32. Horning KK, Hoehns JD, Doucette WR (2007) Adherence to clinical practice guidelines for 7 chronic conditions in long-termcare patients who received pharmacist disease management services versus traditional drug regimen review. J Manag Care Pharm 13:28-36 (Pubitemid 46824248)
33. Hovstadius B, Petersson G (2011) Non-adherence to drug therapy and drug acquisition costs in a national population - a patient-based register study. BMC Health Serv Res 11:326
34. Huffman MH (2009) HEALTH COACHING: a fresh, new approach to improve quality outcomes and compliance for patients with chronic conditions. Home Healthc Nurse 27:490-496
35. Kaye JA, Li L, Jick SS (2008) Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol 159:895-902
36. Kennedy A, Nelson E, Reeves D, Richardson G, Roberts C, Robinson A, Rogers A, Sculpher M, Thompson D (2003) A randomised controlled trial to assess the impact of a package comprising a patient-orientated, evidence-based self-help guide-book and patient-centred consultations on disease management and satisfaction in inflammatory bowel disease. Health Technol Assess 7:3 1-iii113
37. Koo J (1996) Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin 14:485-496
38. Kravitz RL, Hays RD, Sherbourne CD, Dimatteo MR, Rogers WH, Ordway L, Greenfield S (1993) Recall of recommendations and adherence to advice among patients with chronic medical conditions. Arch Intern Med 153:1869-1878 (Pubitemid 23329841)
39. Kripalani S, Robertson R, Love-Ghaffari MH, Henderson LE, Praska J, Strawder A, Katz MG, Jacobson TA (2007) Development of an illustrated medication schedule as a low-literacy patient education tool. Patient Educ Couns 66:368-377 (Pubitemid 46726957)
40. Kripalani S, Yao X, Haynes RB (2007) Interventions to enhance medication adherence in chronic medical conditions: a systematic review. Arch Intern Med 167:540-550 (Pubitemid 46513223)
41. Kucukarslan SN, Thomas S, Bazzi A, Virant-Young D (2009) Using self-regulation theory to examine patient goals, barriers, and facilitators for taking medication. Patient 2:211-220
42. Langley RG, Ellis CN (2004) Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment. J Am Acad Dermatol 51:563-569 (Pubitemid 39278075)
43. Langley RG, Krueger GG, Griffiths CE (2005) Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 64(Suppl 2):ii18-ii23 (Pubitemid 40288514)
44. Lawrence DB, Allison W, Chen JC, Demand M (2008) Improving medication adherence with a targeted, technology-driven disease management intervention. Dis Manag 11:141-144 (Pubitemid 351871684)
45. Lebwohl M, Ali S (2001) Treatment of psoriasis. Part 1. Topical therapy and phototherapy. J Am Acad Dermatol 45:487-498 (Pubitemid 32917240)
46. Lee IA, Maibach HI (2006) Pharmionics in dermatology: a review of topical medication adherence. Am J Clin Dermatol 7:231-236 (Pubitemid 44231918)
47. Leiva A, Fajo M, Escriche L, Audera FJ, Lopez S, Martin MC, Gonzalez R, Tamborero G, Garcia EM, Duro R, Orueta R, Serra F, D'agosto PP, Miralles J, Lorente P, Llobera J, Iglesias AA, Fernandez R, Colom MM, Buades AM, Moreno L, Vidal C (2010) Efficacy of a brief multifactorial adherence-based intervention on reducing the blood pressure of patients with poor adherence: protocol for a randomized clinical trial. BMC Cardiovasc Disord 10:44. doi:10.1186/1471-2261- 10-44.:44-10
48. Lowes MA, Bowcock AM, Krueger JG (2007) Pathogenesis and therapy of psoriasis. Nature 445:866-873
49. Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M (1999) Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. Br J Dermatol 141:1067-1075 (Pubitemid 30046197)
50. Martin LR, Williams SL, Haskard KB, Dimatteo MR (2005) The challenge of patient adherence. Ther Clin Risk Manag 1:189-199
51. Matsui D (2009) Strategies to measure and improve patient adherence in clinical trials. Pharm Med 23:289-297
52. Menter A, Griffiths CE (2007) Current and future management of psoriasis. Lancet 370:272-284 (Pubitemid 47071926)
53. Mosen DM, Schmittdiel J, Hibbard J, Sobel D, Remmers C, Bellows J (2007) Is patient activation associated with outcomes of care for adults with chronic conditions? J Ambul Care Manage 30:21-29 (Pubitemid 46005839)
54. Mrowietz U, Kragballe K, Reich K, Spuls P, Griffiths CE, Nast A, Franke J, Antoniou C, Arenberger P, Balieva F, Bylaite M, Correia O, Dauden E, Gisondi P, Iversen L, Kemeny L, Lahfa M, Nijsten T, Rantanen T, Reich A, Rosenbach T, Segaert S, Smith C, Talme T, Volc-Platzer B, Yawalkar N (2011) Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res 303:1-10
55. Mullen PD, Green LW, Persinger GS (1985) Clinical trials of patient education for chronic conditions: a comparative meta-analysis of intervention types. Prev Med 14:753-781 (Pubitemid 16175940)
56. Nast A, Boehncke W-H, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Sammain A, Schlaeger M, Sebastian M, Sterry W, Streit V, Augustin M, Erdmann R, Klaus J, Koza J, Müller S, Orzechowski HD, Rosumeck S, Schmid-Ott G, Weberschock T, Rzany B (2011) S3-Leitlinie zur Therapie der Psoriasis vulgaris Update 2011. J Dtsch Dermatol Ges 9:S1-S104
57. Nast A, Erdmann R, Pathirana D, Rzany B (2008) Translating psoriasis treatment guidelines into clinical practice - the need for educational interventions and strategies for broad dissemination. J Eval Clin Pract 14:803-806
58. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM (2006) Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 55:829-835 (Pubitemid 44556851)
59. Nichol MB, Knight TK, Priest JL, Wu J, Cantrell CR (2010) Nonadherence to clinical practice guidelines and medications for multiple chronic conditions in a California Medicaid population. J Am Pharm Assoc (2003) 50:496-507
60. Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353:487-497 (Pubitemid 41127293)
61. Pagliarello C, Di PC, Paradisi A, Abeni D, Tabolli S (2010) Measuring empowerment in patients with psoriasis: the Psoriasis Empowerment Enquiry in the Routine Practice (PEER) questionnaire. Eur J Dermatol 20:200-204
62. Renzi C, Abeni D, Picardi A, Agostini E, Melchi CF, Pasquini P, Puddu P, Braga M (2001) Factors associated with patient satisfaction with care among dermatological outpatients. Br J Dermatol 145:617-623
63. Renzi C, Tabolli S, Picardi A, Abeni D, Puddu P, Braga M (2005) Effects of patient satisfaction with care on health-related quality of life: a prospective study. J Eur Acad Dermatol Venereol 19:712-718 (Pubitemid 41743324)
64. Richards HL, Fortune DG, Griffiths CE (2006) Adherence to treatment in patients with psoriasis. J Eur Acad Dermatol Venereol 20:370-379
65. Richards HL, Fortune DG, O'Sullivan TM, Main CJ, Griffiths CE (1999) Patients with psoriasis and their compliance with medication. J Am Acad Dermatol 41:581-583 (Pubitemid 29480408)
66. Riley KM, Glasgow RE, Eakin EG (2001) Resources for health: a social-ecological intervention for supporting self-management of chronic conditions. J Health Psychol 6:693-705 (Pubitemid 33078609)
67. Sabaté E (2003) Adherence to long-term therapies - evidence for action, WHO, WHO1-211 http://apps.who.int/medicinedocs/pdf/s4883e/s4883e.pdf, Accessed 16 Jan 2014
68. Sackett DL, Haynes RB, Gibson ES, Taylor DW, Roberts RS, Johnson AL (1978) Patient compliance with antihypertensive regimens. Patient Couns Health Educ 1:18-21 (Pubitemid 9071898)
69. Sahm L, MacCurtain A, Hayden J, Roche C, Richards HL (2009) Electronic reminders to improve medication adherence-are they acceptable to the patient? Pharm World Sci 31:627-629
70. Schoffski O, Augustin M, Prinz J, Rauner K, Schubert E, Sohn S, Reich K (2007) Costs and quality of life in patients with moderate to severe plaque-type psoriasis in Germany: a multi-center study. J Dtsch Dermatol Ges 5:209-218 (Pubitemid 46361354)
71. Schulman BA, Swain MA (1980) Active patient orientation. Patient Couns Health Educ 2:32-37 (Pubitemid 10088867)
72. Sohn S, Schoeffski O, Prinz J, Reich K, Schubert E, Waldorf K, Augustin M (2006) Cost of moderate to severe plaque psoriasis in Germany: a multicenter cost-of-illness study. Dermatology 212:137-144 (Pubitemid 43260729)
73. Stein GL, Corvari L (2007) The roles of safety and compliance in determining effectiveness of topical therapy for psoriasis. Cutis 79:32-38
74. Stilley CS, Bender CM, Dunbar-Jacob J, Sereika S, Ryan CM (2010) The impact of cognitive function on medication management: three studies. Health Psychol 29:50-55
75. Storm A, Andersen SE, Benfeldt E, Serup J (2008) One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol 59:27-33
76. Storm A, Benfeldt E, Andersen SE, Andersen J (2009) Basic drug information given by physicians is deficient, and patients' knowledge low. J Dermatol Treat 20:190-193
77. Storm A, Benfeldt E, Andersen SE, Serup J (2008) A prospective study of patient adherence to topical treatments: 95% of patients underdose. J Am Acad Dermatol 59:975-980
78. Uhlenhake EE, Kurkowski D, Feldman SR (2010) Conversations on psoriasis - what patients want and what physicians can provide: a qualitative look at patient and physician expectations. J Dermatol Treat 21:6-12
79. van de Kerkhof PC, de Hoop D, de Korte J, Cobelens SA, Kuipers MV (2000) Patient compliance and disease management in the treatment of psoriasis in the Netherlands. Dermatology 200:292-298 (Pubitemid 30451575)
80. Williams A, Manias E, Walker R (2008) Interventions to improve medication adherence in people with multiple chronic conditions: a systematic review. J Adv Nurs 63:132-143
81. Zaghloul SS, Goodfield MJ (2004) Objective assessment of compliance with psoriasis treatment. Arch Dermatol 140:408-414 (Pubitemid 38469243)
82. Zschocke I, Mrowietz U, Lotzin A, Karakasili E, Reich K (2014) Assessing adherence factors in patients under topical treatment: development of the Topical Therapy Adherence Questionnaire (TTAQ). Arch Dermatol Res 306:287-297